{"id":51043,"date":"2022-11-18T17:02:35","date_gmt":"2022-11-18T16:02:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/north-america-human-leukocyte-antigen-testing-market-report-2022-rising-government-funding-for-organ-donation-presents-opportunities-researchandmarkets-com\/"},"modified":"2022-11-18T17:02:35","modified_gmt":"2022-11-18T16:02:35","slug":"north-america-human-leukocyte-antigen-testing-market-report-2022-rising-government-funding-for-organ-donation-presents-opportunities-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/north-america-human-leukocyte-antigen-testing-market-report-2022-rising-government-funding-for-organ-donation-presents-opportunities-researchandmarkets-com\/","title":{"rendered":"North America Human Leukocyte Antigen Testing Market Report 2022: Rising Government Funding for Organ Donation Presents Opportunities – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “North America Human Leukocyte Antigen Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Product and service, Technology, and End User”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe North America human leukocyte antigen (HLA) testing market is expected to grow from US$ 324.49 million in 2022 to US$ 504.72 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.\n<\/p>\n

\nHuman leukocyte antigens (HLAs) are specialized proteins present on all cell surfaces of the human body except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues.\n<\/p>\n

\nThe growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice area. Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures.\n<\/p>\n

\nFor instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying the organ transplantation waitlist by redistributing the existing organ soppy.\n<\/p>\n

\nFurthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization. Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the HLA testing market.\n<\/p>\n

\nWith new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the north america human leukocyte antigen (HLA) testing market at a notable CAGR during the forecast period.\n<\/p>\n

\nMarket Dynamics<\/strong>\n<\/p>\n

\nMarket Drivers\n<\/p>\n